Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 16 | 2026 | 1662 | 2.610 |
Why?
|
| Image-Guided Biopsy | 5 | 2025 | 50 | 2.180 |
Why?
|
| Pancreatic Neoplasms | 4 | 2023 | 354 | 1.800 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2023 | 128 | 1.290 |
Why?
|
| Adenocarcinoma | 2 | 2021 | 367 | 1.090 |
Why?
|
| Intestines | 2 | 2025 | 184 | 0.980 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 2025 | 1 | 0.890 |
Why?
|
| Abdomen | 1 | 2023 | 97 | 0.770 |
Why?
|
| Ischemia | 1 | 2025 | 203 | 0.760 |
Why?
|
| Retrospective Studies | 17 | 2026 | 6948 | 0.710 |
Why?
|
| Sarcopenia | 1 | 2022 | 28 | 0.710 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2022 | 52 | 0.700 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2021 | 16 | 0.700 |
Why?
|
| Margins of Excision | 1 | 2021 | 31 | 0.690 |
Why?
|
| Brachytherapy | 1 | 2021 | 40 | 0.680 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2022 | 109 | 0.670 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 710 | 0.490 |
Why?
|
| Mesentery | 2 | 2025 | 17 | 0.460 |
Why?
|
| Omentum | 2 | 2025 | 14 | 0.450 |
Why?
|
| Radiography, Interventional | 2 | 2025 | 83 | 0.400 |
Why?
|
| Contrast Media | 5 | 2026 | 432 | 0.400 |
Why?
|
| Aged | 10 | 2026 | 15089 | 0.350 |
Why?
|
| Humans | 25 | 2026 | 65645 | 0.340 |
Why?
|
| Middle Aged | 11 | 2026 | 18439 | 0.330 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2025 | 2262 | 0.300 |
Why?
|
| Female | 12 | 2026 | 34309 | 0.260 |
Why?
|
| Rectus Abdominis | 1 | 2026 | 4 | 0.240 |
Why?
|
| Male | 9 | 2026 | 31292 | 0.240 |
Why?
|
| Muscular Diseases | 1 | 2026 | 51 | 0.230 |
Why?
|
| Hematoma | 1 | 2026 | 85 | 0.230 |
Why?
|
| Peritoneal Neoplasms | 1 | 2025 | 31 | 0.230 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2026 | 113 | 0.210 |
Why?
|
| Kidney Neoplasms | 1 | 2026 | 173 | 0.210 |
Why?
|
| Endometrial Neoplasms | 1 | 2025 | 77 | 0.200 |
Why?
|
| Cysts | 2 | 2014 | 44 | 0.200 |
Why?
|
| Pelvis | 1 | 2023 | 64 | 0.200 |
Why?
|
| Algorithms | 3 | 2023 | 1052 | 0.190 |
Why?
|
| Dissent and Disputes | 1 | 2022 | 9 | 0.190 |
Why?
|
| Incidental Findings | 1 | 2022 | 51 | 0.180 |
Why?
|
| Intra-Abdominal Fat | 1 | 2022 | 37 | 0.180 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 1116 | 0.180 |
Why?
|
| Body Composition | 1 | 2022 | 155 | 0.180 |
Why?
|
| Iodine Radioisotopes | 1 | 2021 | 60 | 0.170 |
Why?
|
| Pancreatic Ducts | 1 | 2021 | 31 | 0.170 |
Why?
|
| Iodine | 1 | 2021 | 21 | 0.170 |
Why?
|
| Preoperative Care | 1 | 2021 | 199 | 0.160 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 308 | 0.150 |
Why?
|
| Aged, 80 and over | 4 | 2025 | 5656 | 0.150 |
Why?
|
| Heart Transplantation | 1 | 2021 | 180 | 0.150 |
Why?
|
| Endovascular Procedures | 1 | 2026 | 631 | 0.150 |
Why?
|
| Patient Safety | 1 | 2022 | 281 | 0.140 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 158 | 0.140 |
Why?
|
| Lung | 1 | 2023 | 969 | 0.140 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 188 | 0.140 |
Why?
|
| Prevalence | 1 | 2022 | 1453 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2021 | 1026 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2023 | 76 | 0.130 |
Why?
|
| Machine Learning | 1 | 2020 | 196 | 0.130 |
Why?
|
| Radiation Dosage | 3 | 2023 | 140 | 0.130 |
Why?
|
| Kidney Transplantation | 1 | 2019 | 326 | 0.120 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1715 | 0.120 |
Why?
|
| Adult | 6 | 2025 | 17511 | 0.110 |
Why?
|
| Laparoscopy | 1 | 2019 | 492 | 0.110 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 142 | 0.100 |
Why?
|
| Superinfection | 1 | 2014 | 12 | 0.100 |
Why?
|
| Multidetector Computed Tomography | 1 | 2014 | 22 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2016 | 142 | 0.100 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2014 | 22 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 68 | 0.100 |
Why?
|
| Heart Failure | 1 | 2021 | 965 | 0.100 |
Why?
|
| Liver Diseases | 1 | 2013 | 157 | 0.090 |
Why?
|
| Phantoms, Imaging | 2 | 2023 | 239 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 1233 | 0.080 |
Why?
|
| Sepsis | 1 | 2014 | 302 | 0.080 |
Why?
|
| Kidney | 2 | 2021 | 458 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2022 | 704 | 0.070 |
Why?
|
| Portal Vein | 1 | 2026 | 39 | 0.060 |
Why?
|
| Biopsy, Large-Core Needle | 1 | 2025 | 22 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2022 | 3329 | 0.050 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2025 | 63 | 0.050 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 992 | 0.050 |
Why?
|
| Ultrasonography, Interventional | 1 | 2025 | 124 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2025 | 552 | 0.050 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2023 | 61 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2026 | 5820 | 0.050 |
Why?
|
| Embolization, Therapeutic | 1 | 2026 | 337 | 0.050 |
Why?
|
| Radiologists | 1 | 2022 | 93 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2025 | 741 | 0.040 |
Why?
|
| ROC Curve | 1 | 2021 | 294 | 0.040 |
Why?
|
| Meglumine | 1 | 2020 | 21 | 0.040 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2019 | 30 | 0.040 |
Why?
|
| Organometallic Compounds | 1 | 2020 | 71 | 0.040 |
Why?
|
| Living Donors | 1 | 2019 | 78 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 121 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2019 | 93 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2021 | 301 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 593 | 0.030 |
Why?
|
| Obesity | 1 | 2023 | 1277 | 0.030 |
Why?
|
| Hematuria | 1 | 2014 | 23 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2014 | 157 | 0.020 |
Why?
|
| United States | 1 | 2022 | 8166 | 0.020 |
Why?
|
| Hypertension | 1 | 2014 | 616 | 0.020 |
Why?
|